Q2 2009

Filed Aug 9, 2010 · 10-Q · 40 days after period end · 0001062822-10-000042

Q2 2009 · 10-Q

Revenue

$1.23M

no prior Q2 2008 on file

Net Income

-$25.19M

no prior Q2 2008 on file

EPS Diluted

-$0.07

no prior Q2 2008 on file

Operating Income-$24,074,000—

Margins · derived

Same quarter

no prior Q2 2008 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 9, 2010 · 40 d after period end

Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR